文献速递妇科

美国子宫内膜癌治疗中微创手术的采用与手术并发症下降

Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States.
PubMed 文献 · Obstet Gynecol · 2018-01-01

这项回顾性队列研究基于美国外科医师学会国家手术质量改进项目2008-2014年数据库,纳入12,283例子宫内膜癌手术患者。微创手术比例从24.2%升至71.4%,开腹手术从71.1%降至26.4%(均P<.001)。调整混杂后,开腹手术较微创手术的30天主要并发症、再入院、再手术、浅表手术部位感染、围术期输血和死亡风险均升高。

要点

  • 2008至2014年微创手术比例由24.2%升至71.4%,开腹手术由71.1%降至26.4%。
  • 开腹手术较微创手术的主要并发症调整OR为2.4(95%CI 2.0-2.8)。
  • 开腹手术较微创手术的死亡调整OR为3.8(95%CI 2.2-6.6)。

核心结论

  • 微创手术的广泛采用与美国子宫内膜癌患者30天并发症、再入院和再手术的大幅下降相关。

研究设计与样本

  • 回顾性队列研究,审查美国外科医师学会国家手术质量改进项目2008-2014年数据库,纳入按主要现行操作术语(CPT)编码行子宫内膜癌手术的患者12,283例,排除晚期或播散性病变编码者。

主要发现

  • 2008至2014年微创手术比例由24.2%升至71.4%,开腹手术由71.1%降至26.4%(均P<.001);阴道手术比例无变化(1.5%至2.2%,P=.06)。
  • 调整混杂后,开腹手术较微创手术的主要并发症例数347 vs 274,调整OR 2.4(95%CI 2.0-2.8)。
  • 开腹手术较微创手术的再入院例数269 vs 238,调整OR 2.2(95%CI 1.8-2.6);再手术例数80 vs 93,调整OR 1.5(95%CI 1.2-2.1)。
  • 开腹手术较微创手术的浅表手术部位感染例数190 vs 55,调整OR 6.8(95%CI 5.0-9.2);围术期输血例数430 vs 149,调整OR 5.9(95%CI 4.8-7.1)。
  • 开腹手术较微创手术的死亡例数41 vs 20,调整OR 3.8(95%CI 2.2-6.6);2008至2014年整体30天并发症下降(P<.001),30天死亡率保持稳定(P=.24)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess how the widespread adoption of minimally invasive surgery in the United States is associated with changes in 30-day morbidity and mortality in endometrial cancer treatment. METHODS: In this retrospective cohort study, the American College of Surgeons' National Surgical Quality Improvement Project database for 2008-2014 was reviewed for patients who had undergone surgery for endometrial cancer according to their primary Current Procedural Terminology (CPT) codes. Women with CPT codes for advanced cancer or with disseminated disease were excluded. A trend analysis across the time period by surgical approach (open surgery through laparotomy, vaginal surgery, and minimally invasive surgery) was performed using a Cochran-Armitage test for trend. Thirty-day surgical outcomes were compared between patients who had minimally invasive surgery and open surgery. Inverse probability of treatment weighting models were used to investigate the independent effect of minimally invasive surgery on 30-day outcomes. RESULTS: Overall, 12,283 patients met the inclusion criteria. A significant implementation of minimally invasive surgery (24.2-71.4%) and a concomitant decrease in open surgery through laparotomy (71.1-26.4%) were observed from 2008 to 2014 (both P<.001). Rate of vaginal surgery did not change over time (1.5-2.2%, P=.06). After adjusting for possible confounders, open surgery (compared with minimally invasive surgery) was independently associated with increased odds of major complications (n=347 versus n=274, adjusted odds ratio [OR] 2.4, 95% CI 2.0-2.8), readmission (n=269 versus n=238, adjusted OR 2.2, 95% CI 1.8-2.6), reoperation (n=80 versus n=93, adjusted OR 1.5, 95% CI 1.2-2.1), superficial surgical site infection (n=190 versus n=55, adjusted OR 6.8, 95% CI 5.0-9.2), perioperative transfusion (n=430 versus n=149, adjusted OR 5.9, 95% CI 4.8-7.1), and death (n=41 vs, n=20, adjusted OR 3.8, 95% CI 2.2-6.6). A comprehensive decrease in 30-day morbidity for the treatment of endometrial cancer overall was observed from 2008 to 2014 (P<.001), whereas 30-day mortality remained stable (P=.24). CONCLUSION: The widespread adoption of minimally invasive surgery is associated with substantial decreases in 30-day morbidity, readmission, and reoperation for women treated for endometrial cancer in the United States.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Casarin J, Multinu F, Ubl DS, et al. Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States. Obstet Gynecol. 2018. PMID: 29324598. doi:10.1097/AOG.0000000000002428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。